Expiration Date: 03/05/2025
Learner Notification
*Please note that you must complete the Post Webinar Evaluation (link below) to receive CE credit.
Speakers
Michael B Marlin, MD
Medical Director
Mississippi PC
Has disclosed no relevant financial relationships
Moderator
Christopher Hoyte, MD, FAACT
Medical Director
Rocky Mountain Poison Center
Has disclosed no relevant financial relationships
Organizer
David Vearrier, MD, MPH
Professor of Emergency Medicine
University of Mississippi Medical Center
Has disclosed no relevant financial relationships
Description
In this session, we will explore the evolving landscape of doping practices, focusing on the use of anti-ischemic agents among other substances. Our aim is to provide a comprehensive overview of how these drugs are manipulated to enhance athletic performance, along with a critical analysis of their potential toxicities and health implications. This knowledge is important not only for those directly involved in sports medicine but for all healthcare providers, as it enhances the understanding of drug misuse and its impact on health and ethics in the sporting world.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire webinar as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Physicians and Pharmacists
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Academy of Clinical Toxicology. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM for physicians and 1 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of the activity to meet the deadline for submission to CPE Monitor.
Objectives - After attending this program you should be able to:
- Understand the pharmacological mechanisms and effects of anti-ischemic agents and other commonly used performance-enhancing drugs in sports.
- Identify the signs and symptoms of toxicity due to doping and develop strategies for its management.
- Equip participants with the knowledge to ethically counsel athletes and other stakeholders about the risks of doping.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.
Click here to complete the Post Webinar CE Evaluation